Sandoz will cut 50 jobs in Wilson

July 14, 2009 

— Sandoz, a division of Swiss pharmaceutical manufacturer Novartis, plans to shut down a research and development operation in Wilson, putting 50 people out of work in September.

The company, which makes generic drugs, said in a filing with the N.C. Department of Commerce that it will eliminate R&D and regulatory affairs positions at the site.

The cuts will take effect around Sept. 11.

Sandoz operates a manufacturing plant in Wilson, one of three in the United States.

It's unclear whether the planned job cuts will have any effect on the factory.

Efforts to reach a Sandoz spokesman Monday were unsuccessful.

News & Observer is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service